Hyderabad: Pulsus Group plans to set up an AI-based pharma healthcare IT hub at Ameenpur in Sangareddy district of Telangana at an estimated cost of Rs 300 crore and a potential to create around 50,000 jobs.
Announcing this at the inaugural day of the 73rd Indian Pharmaceutical Congress here on Friday, Pulsus Group CEO & managing director Dr Srinubabu Gedela said the project will catalyse the healthcare and IT landscape with an estimated 10,000 direct jobs and around 40,000 indirect jobs through supporting industries and services.
To be located within the IT/ITeS zone in Ameenpur, the project will utilise AI innovations to enrich all aspects of pharma, from research and development to healthcare delivery and generate a sizable number of jobs for residents, he said.
“By integrating the most advanced artificial intelligence, we aim to streamline processes, enhance precision in drug development, and improve patient outcomes. This positions Telangana at the forefront of healthcare innovation in India,” Gedela said.
Addressing the conclave, Telangana industries & IT minister D Sridhar Babu said the pharma industry embracing AI and other cutting-edge technologies should help make drugs and treatments more affordable for patients.
To further boost Telangana and Hyderabad’s prospects as a global pharma capital, Telangana chief minister A Revanth Reddy has decided to take the cluster-based and decentralised development approach with 9-10 pharma zones across the state to ensure a self-sustaining ecosystem and generate employment in rural areas, he said.
Over 12,000 delegates, including pharmacy students, are participating in the three-day conclave.